156 related articles for article (PubMed ID: 10219988)
1. Pharmacokinetics of the toxic fraction of Centruroides limpidus limpidus venom in experimentally envenomed rabbits and effects of immunotherapy with specific F(ab')2.
Calderón-Aranda ES; Rivière G; Choumet V; Possani LD; Bon C
Toxicon; 1999 May; 37(5):771-82. PubMed ID: 10219988
[TBL] [Abstract][Full Text] [Related]
2. Mortality and antibody responses of mice to three successive episodes of experimental scorpion (Centruroides limpidus limpidus) envenomation and immunological rescue.
Padilla A; Govezensky T; Possani LD; Larralde C
Toxicon; 2005 Aug; 46(2):142-9. PubMed ID: 15946719
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of 125I-labelled IgG, F(ab')2 and Fab fractions of scorpion and snake antivenins: merits and potential for therapeutic use.
Ismail M; Abd-Elsalam MA
Toxicon; 1998 Nov; 36(11):1523-8. PubMed ID: 9792168
[TBL] [Abstract][Full Text] [Related]
4. Immunotherapy for scorpion envenoming in Brazil.
Rezende NA; Amaral CF; Freire-Maia L
Toxicon; 1998 Nov; 36(11):1507-13. PubMed ID: 9792165
[TBL] [Abstract][Full Text] [Related]
5. Toxicokinetic and toxicodynamic analyses of Androctonus australis hector venom in rats: optimization of antivenom therapy.
Hammoudi-Triki D; Lefort J; Rougeot C; Robbe-Vincent A; Bon C; Laraba-Djebari F; Choumet V
Toxicol Appl Pharmacol; 2007 Feb; 218(3):205-14. PubMed ID: 17198719
[TBL] [Abstract][Full Text] [Related]
6. Immunoreactivity and pharmacokinetics of horse anti-scorpion venom F(ab')2-scorpion venom interactions.
Pépin-Covatta S; Lutsch C; Grandgeorge M; Lang J; Scherrmann JM
Toxicol Appl Pharmacol; 1996 Nov; 141(1):272-7. PubMed ID: 8917700
[TBL] [Abstract][Full Text] [Related]
7. Effect of antivenom on venom pharmacokinetics in experimentally envenomed rabbits: toward an optimization of antivenom therapy.
Rivière G; Choumet V; Audebert F; Sabouraud A; Debray M; Scherrmann JM; Bon C
J Pharmacol Exp Ther; 1997 Apr; 281(1):1-8. PubMed ID: 9103473
[TBL] [Abstract][Full Text] [Related]
8. Antivenom for critically ill children with neurotoxicity from scorpion stings.
Boyer LV; Theodorou AA; Berg RA; Mallie J; ; Chávez-Méndez A; García-Ubbelohde W; Hardiman S; Alagón A
N Engl J Med; 2009 May; 360(20):2090-8. PubMed ID: 19439743
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetic studies of scorpion venom before and after antivenom immunotherapy.
Krifi MN; Savin S; Debray M; Bon C; El Ayeb M; Choumet V
Toxicon; 2005 Feb; 45(2):187-98. PubMed ID: 15626368
[TBL] [Abstract][Full Text] [Related]
10. Modelling Tityus scorpion venom and antivenom pharmacokinetics. Evidence of active immunoglobulin G's F(ab')2 extrusion mechanism from blood to tissues.
Sevcik C; D'Suze G; Díaz P; Salazar V; Hidalgo C; Azpúrua H; Bracho N
Toxicon; 2004 Dec; 44(7):731-41. PubMed ID: 15500849
[TBL] [Abstract][Full Text] [Related]
11. Effects of antivenom on Buthus occitanus tunetanus (Bot) scorpion venom pharmacokinetics: towards an optimization of antivenom immunotherapy in a rabbit model.
Krifi MN; Miled K; Abderrazek M; El Ayeb M
Toxicon; 2001 Sep; 39(9):1317-26. PubMed ID: 11384719
[TBL] [Abstract][Full Text] [Related]
12. Scorpion envenomation and serotherapy in Morocco.
Ghalim N; El-Hafny B; Sebti F; Heikel J; Lazar N; Moustanir R; Benslimane A
Am J Trop Med Hyg; 2000 Feb; 62(2):277-83. PubMed ID: 10813485
[TBL] [Abstract][Full Text] [Related]
13. Preparation of a polyvalent antivenom against various Mexican scorpion Centruroides species.
Garcia y Perez G; Martin MF; Rochat H
Toxicon; 1988; 26(11):1102-6. PubMed ID: 3245056
[TBL] [Abstract][Full Text] [Related]
14. Amelioration of cardio-respiratory perturbations following Mesobuthus eupeus envenomation in anesthetized rabbits with commercial polyvalent F(ab')2 antivenom.
Zayerzadeh E; Koohi MK; Mirakabadi AZ; Fardipoor A; Kassaian SE; Rabbani S; Anvari MS
Toxicon; 2012 Feb; 59(2):249-56. PubMed ID: 22118980
[TBL] [Abstract][Full Text] [Related]
15. The venom of the scorpion Centruroides limpidus, which causes the highest number of stings in Mexico, is neutralized by two recombinant antibody fragments.
Fernández-Taboada G; Riaño-Umbarila L; Olvera-Rodríguez A; Gómez-Ramírez IV; Losoya-Uribe LF; Becerril B
Mol Immunol; 2021 Sep; 137():247-255. PubMed ID: 34298407
[TBL] [Abstract][Full Text] [Related]
16. Experimental treatment protocols for scorpion envenomation: a review of common therapies and an effect of kallikrein-kinin inhibitors.
Ismail M; Fatani AJ; Dabees TT
Toxicon; 1992 Oct; 30(10):1257-79. PubMed ID: 1279839
[TBL] [Abstract][Full Text] [Related]
17. A novel human recombinant antibody fragment capable of neutralizing Mexican scorpion toxins.
Riaño-Umbarila L; Olamendi-Portugal T; Morelos-Juárez C; Gurrola GB; Possani LD; Becerril B
Toxicon; 2013 Dec; 76():370-6. PubMed ID: 24067940
[TBL] [Abstract][Full Text] [Related]
18. Preparation of F(ab')
Ismael BN; Abass KS; Khalil KA; Salih KA
Biologicals; 2018 Nov; 56():19-23. PubMed ID: 30153952
[TBL] [Abstract][Full Text] [Related]
19. Development and Efficacy of the Antivenom Specific to Severe Envenomations in Morocco and North Africa: Advancements in Scorpion Envenomation Management.
Darkaoui B; Hilal I; Khourcha S; Lafnoune A; Chakir S; Aarab A; Moustaghfir A; Filali OA; Oukkache N
Toxins (Basel); 2024 May; 16(5):. PubMed ID: 38787066
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetic-pharmacodynamic relationships of immunoglobulin therapy for envenomation.
Gutiérrez JM; León G; Lomonte B
Clin Pharmacokinet; 2003; 42(8):721-41. PubMed ID: 12846594
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
